Skip to content

Evaluation of the use of Probiotics for infant colic

Effect of using Probiotics (Lactobacillus acidophilus) on colic in infants: a double-blind randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5pp4nks
Enrollment
Unknown
Registered
2023-09-09
Start date
2021-06-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colic

Interventions

This is a two-arm, double-blind, randomized controlled clinical trial. The sample of the present study will be composed of infants who developed colic according to the Rome IV criteria, between 2 and
G07.203.300.456.500

Sponsors

Universidade Federal de Goiás
Lead Sponsor
Cifarma ltda
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Infants with mothers aged 18 or over will be selected; infants aged between 2 and 12 completed weeks of life; born at term, with a birth weight of 2500 g or more; who present uncontrollable crying for at least 3 hours a day and 3 days a week for at least one week (according to the criteria of ROME IV)

Exclusion criteria

Exclusion criteria: Infants who were exposed to the use of probiotics before or during the study will be excluded; and/or who have gastroesophageal reflux disease using specific medication (proton pump and/or prokinetic inhibitors); and/or who have gastrointestinal tract malformations; and/or who need to use antibiotics during the study

Design outcomes

Primary

MeasureTime frame
It is expected to find a greater decrease between the mean initial and final crying time (day 28) in the group that received the probiotic compared to the placebo

Secondary

MeasureTime frame
It is expected to find variations in the concentration of fecal calprotectin, through the stool samples collected at the beginning and end of the study, with lower levels in the placebo group;Evaluate the number of infants responding to the probiotic (infants who reduced at least 50% of crying time in minutes) when compared to the beginning of the intervention. The number of responders in the probiotic group is estimated to be significantly higher than the placebo group;Compare changes in the microbiota profile of the infant with colic. This will be verified by analyzing the infant's microbiota before and after the intervention using the 16S-RNA technique. significant differences between the groups are expected

Countries

Brazil

Contacts

Public ContactSaskia Vaz

Universidade Federal de Goiás

saskiaribeirovaz@gmail.com+55 (62) 98100-2263

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Apr 20, 2026